Future research on cathepsins in cancer should focus on elucidating their specific roles in different cancer types and stages. Investigating the interplay between cathepsins and other proteases, as well as their interactions with the tumor microenvironment, could reveal novel therapeutic targets. Additionally, developing more selective and potent cathepsin inhibitors with minimal side effects remains a key area of interest.
